Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2

The miRNA microarray analysis showed that miR-31 was reduced in gastric cancer. This study further assessed miR-31 expression and role of miR-31 in gastric cancer tissues and cell lines. The data showed that miR-31 expression was down-regulated in 40 cases of gastric cancer tissues compared to the adjacent normal tissues, and low expression of miR-31 was associated with poor tumor differentiation, lymph node metastasis, advanced T stage and worse overall survival of gastric cancer patients. Ectopic expression of miR-31 reduced tumor cell viability, enhanced apoptosis, arrested tumor cells at G1 transition, and reduced tumor cell migration and invasion in SGC-7901 and MGC-803 gastric cell lines in vitro. Enforced expression of miR-31 also inhibited growth of engrafted tumors in vivo. Luciferase reporter assays and western blot revealed that E2F2 is the direct target of miR-31. E2F2 expression was upregulated in gastric cancer tissues, and inversely associated with miR-31 levels, while knockdown of E2F2 expression mimicked miR-31 anti-tumor activity in gastric cancer cells, but the ectopic expression of E2F2 rescued the miR-31-mediated inhibition in gastric cell lines. Taken together, these results demonstrated that miR-31 acts as a crucial tumor suppressive activity by inhibiting E2F2s expression. Thus, miR-31 might be a candidate therapeutic target for gastric cancer patients.

[1]  K. Rajapakshe,et al.  Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer , 2016, Oncogene.

[2]  W. Allum,et al.  Does surgery have a role in managing incurable gastric cancer? , 2015, Nature Reviews Clinical Oncology.

[3]  E. Andrechek,et al.  Increased metastasis with loss of E2F2 in Myc-driven tumors , 2015, Oncotarget.

[4]  R. Machiraju,et al.  Redeployment of Myc and E2f1-3 drives Rb deficient cell cycles , 2015, Nature Cell Biology.

[5]  Suk Woo Nam,et al.  MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer , 2015, Oncotarget.

[6]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[7]  S. Mocellin,et al.  Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer. , 2015, The Cochrane database of systematic reviews.

[8]  Fan Li,et al.  Overexpression of E2F mRNAs Associated with Gastric Cancer Progression Identified by the Transcription Factor and miRNA Co-Regulatory Network Analysis , 2015, PloS one.

[9]  E. Andrechek.  HER2/Neu tumorigenesis and metastasis is regulated by E2F activator transcription factors , 2013, Oncogene.

[10]  G. Cheng,et al.  Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy. , 2015, Advanced drug delivery reviews.

[11]  Saeed Tavazoie,et al.  Metastasis-suppressor transcript destabilization through TARBP2 binding of mRNA hairpins , 2014, Nature.

[12]  Cheng Huang,et al.  Promising roles of mammalian E2Fs in hepatocellular carcinoma. , 2014, Cellular signalling.

[13]  M. Peter,et al.  MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells , 2014, Oncogene.

[14]  Hui Zhou,et al.  starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data , 2013, Nucleic Acids Res..

[15]  Julian Downward,et al.  Hmga2 functions as a competing endogenous RNA to promote lung cancer progression , 2013, Nature.

[16]  X. Wang,et al.  Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer , 2013, Oncogene.

[17]  Sheng Wang,et al.  Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer , 2013, Clinical and Translational Oncology.

[18]  Francesca Demichelis,et al.  Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression. , 2013, Cancer research.

[19]  X. Chen,et al.  MicroRNA-31 Activates the RAS Pathway and Functions as an Oncogenic MicroRNA in Human Colorectal Cancer by Repressing RAS p21 GTPase Activating Protein 1 (RASA1)* , 2013, The Journal of Biological Chemistry.

[20]  R. Machiraju,et al.  Canonical and Atypical E2Fs Regulate the Mammalian Endocycle , 2012, Nature Cell Biology.

[21]  S. Tavazoie,et al.  A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells , 2011, Nature.

[22]  D. Weil,et al.  CPEB1, a novel gene silenced in gastric cancer: a Drosophila approach , 2011, Gut.

[23]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[24]  E. Andrechek,et al.  Tumor and Stem Cell Biology Prediction and Genetic Demonstration of a Role for Activator E 2 Fs in Myc-Induced Tumors , 2011 .

[25]  R. Weinberg,et al.  Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis. , 2010, Cancer research.

[26]  Tao Wang,et al.  MicroRNA Let-7a Inhibits Proliferation of Human Prostate Cancer Cells In Vitro and In Vivo by Targeting E2F2 and CCND2 , 2010, PloS one.

[27]  E. Dmitrovsky,et al.  MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. , 2010, The Journal of clinical investigation.

[28]  P. Gunaratne,et al.  Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. , 2010, Cancer research.

[29]  S. Chiou,et al.  miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. , 2010, Cancer research.

[30]  J. Pipas,et al.  E2F1-3 Switch from Activators in Progenitor Cells to Repressors in Differentiating Cells , 2009, Nature.

[31]  Robert A. Weinberg,et al.  A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis , 2009 .

[32]  Doron Betel,et al.  The microRNA.org resource: targets and expression , 2007, Nucleic Acids Res..